netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Aflibercept found 9 matches
Open monograph to display formulary status BNF Category
  Aflibercept  (Eylea®) Eye - Subfoveal choroidal neovascularisation - 11.08.02
  Cytotoxic Drug Aflibercept  (Zaltrap®) Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Update (April 2016): Aflibercept (Zaltrap▼): minimising the risk of osteonecrosis of the jaw (08.01.05)
link in drug section NICE TA 294 Aflibercept solution for injection for treating wet age‑related macular degeneration (11.08.02)
link in drug section NICE TA 305 Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion (11.08.02)
link in drug section NICE TA 346 Aflibercept for treating diabetic macular oedema (11.08.02)
link in drug section NICE TA 409: Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion (11.08.02)
link in drug section NICE TA 486: Aflibercept for treating choroidal neovascularisation (11.08.02)
link in drug section NICE TA307: Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy  (08.01.05)


 
netFormulary